Lilly's rheumatoid arthritis pill rejected by regulators

Eli Lilly says U.S. regulators rejected its much-anticipated pill for the immune disorder rheumatoid arthritis, the drugmaker's second drug development setback since November

from ABC News: Health http://ift.tt/2p3jzMN
via HEALTH